GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Respiratory market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Respiratory market reports here.

NEW Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Sleep Apnea pipeline landscape. The report provides comprehensive information on...

NEW Acute Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Acute Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Bronchitis pipeline landscape. The report provides comprehensive information on...

NEW Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Acute Respiratory Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Respiratory Failure pipeline landscape. The report provides comprehensive...

NEW Obstructive Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Obstructive Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Obstructive Sleep Apnea pipeline landscape. The report provides comprehensive...

NEW Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Bronchiolitis Obliterans Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Bronchiolitis Obliterans pipeline landscape. The report provides comprehensive information on...

NEW Neonatal Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Neonatal Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Neonatal Respiratory Distress Syndrome pipeline landscape. The report...

NEW Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Viral Respiratory Tract Infection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Viral Respiratory Tract Infection pipeline landscape. The report...

NEW Interstitial Lung Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Interstitial Lung Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Interstitial Lung Fibrosis pipeline landscape. The report provides comprehensive...

NEW Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Primary Ciliary Dyskinesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Primary Ciliary Dyskinesia pipeline landscape. The report provides comprehensive...

NEW Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,500
  • May 2022
Respiratory Tract Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Respiratory Tract Infections pipeline landscape. The report provides comprehensive...